title: Central venous port system associated thromboses: outcome in 3498 implantations and literature review.
abstract: METHODS
  From 1 July 1995 to 31 June 2006 we implanted 3498 intravenous port systems. In nearly all cases the indication was vascular access for chemotherapy.
  
  
  RESULTS
  We registered 199 complications (5.7%), mostly infections (n=85 i.e. 2.4%) and thromboses (n=63 i.e. 1.8%).
  
  
  CONCLUSIONS
  Permanent central venous catheters have become standard in the management of patients with malignancies. Because of the improvement of material and design during the past twenty years technical complications have been reduced significantly. The most frequent occurring medical complications are infection and thromboses. In order to further minimize these disadvantages we developed a "best practices" standard for port implantation combining own data with recent studies.
authors.affiliation: Klinik für Gefäss- und Thoraxchirurgie, Klinikum Ernst von Bergmann gGmbH, Potsdam, Deutschland.
authors.forename: Martina
authors.initials: M
authors.lastname: Schumacher
authors.forename: Roland H
authors.initials: RH
authors.lastname: Wagner
references.citation: JPEN J Parenter Enteral Nutr. 1984 Jul-Aug;8(4):399-406
references.pmid: 6431130
references.citation: Gan To Kagaku Ryoho. 1999 Nov;26(13):2055-60
references.pmid: 10584571
references.citation: J Clin Oncol. 2003 Feb 15;21(4):736-9
references.pmid: 12586814
references.citation: Surg Gynecol Obstet. 1988 Apr;166(4):295-301
references.pmid: 3127896
references.citation: Br J Haematol. 1998 Jun;101(3):483-6
references.pmid: 9633891
references.citation: Eur J Surg Oncol. 1998 Jun;24(3):192-9
references.pmid: 9630859
references.citation: World J Surg. 1998 Jan;22(1):12-6
references.pmid: 9465755
references.citation: Thromb Haemost. 1996 Feb;75(2):251-3
references.pmid: 8815570
references.citation: Oncology. 1992;49(6):474-8
references.pmid: 1465287
references.citation: J Vasc Interv Radiol. 1995 Mar-Apr;6(2):255-62
references.pmid: 7787360
references.citation: J Surg Oncol. 1989 May;41(1):39-41
references.pmid: 2716332
references.citation: Eur J Surg. 1993 Jun-Jul;159(6-7):323-7
references.pmid: 8104491
references.citation: Oncology. 1999 Nov;57(4):269-75
references.pmid: 10575310
references.citation: J Cancer Res Clin Oncol. 2004 Apr;130(4):235-41
references.pmid: 14760527
references.citation: Intern Med J. 2002 Mar;32(3):84-8
references.pmid: 11885848
references.citation: J Clin Oncol. 1985 May;3(5):710-7
references.pmid: 3923161
references.citation: Acta Haematol. 2001;106(1-2):69-72
references.pmid: 11549779
references.citation: J Clin Oncol. 1996 Oct;14(10):2731-7
references.pmid: 8874334
references.citation: Eur J Cancer. 1996 Dec;32A(13):2262-6
references.pmid: 9038608
references.citation: N Z Med J. 1991 Jul 10;104(915):284-5
references.pmid: 1852329
references.citation: Cancer. 2001 Sep 1;92(5):1204-12
references.pmid: 11571734
references.citation: Am J Surg. 1984 Nov;148(5):633-6
references.pmid: 6496853
references.citation: Medicine (Baltimore). 1999 Sep;78(5):285-91
references.pmid: 10499070
references.citation: Dtsch Med Wochenschr. 1989 Apr 28;114(17):655-8
references.pmid: 2707133
references.citation: Eur J Surg. 1992 Sep;158(9):481-4
references.pmid: 1358215
references.citation: Oncologist. 2003;8(4):381-8
references.pmid: 12897335
references.citation: J Clin Oncol. 2006 Mar 20;24(9):1404-8
references.pmid: 16549834
references.citation: Surg Annu. 1993;25 Pt 2:45-57
references.pmid: 8351592
references.citation: Radiology. 1990 Nov;177(2):353-6
references.pmid: 2217768
references.citation: Eur Radiol. 1996;6(5):748-52
references.pmid: 8934144
references.citation: Eur J Cancer. 1991;27(2):147-9
references.pmid: 1827278
references.citation: J Clin Oncol. 1993 Nov;11(11):2181-5
references.pmid: 8229132
references.citation: Dtsch Med Wochenschr. 2005 May 6;130(18):1129-32
references.pmid: 15856394